Health Technology Assessment in Action

Published by: Kowsar
Crossmark

Safety and Efficacy of Tomotherapy for Lung Cancer Compared to Other Radiotherapy Techniques: A Systematic Review

Elahe Bavandpour 1 , * , Maryam Bavandpour 2 , Zahra Karimi 3 , Mehrdad Payandeh 4 , Ebrahim Shakiba 5 and Maliheh Dayani 6
Authors Information
1 Department of Vice Chancellor for Care Services, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Department of Vice Chancellor for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Department of Medical Radiation Engineering, Faculty of Advanced Sciences and Technology, Isfahan, Iran
4 Department of Bone Marrow Transplantation, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5 Department of Clinical Biochemistry, Hamadan University of Medical Sciences, Hamadan, Iran
6 Department of Radiation Oncology, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Article information
  • Health Technology Assessment in Action: April 30, 2018, 2 (1); e94241
  • Published Online: July 7, 2019
  • Article Type: Systematic Review
  • Received: May 22, 2019
  • Revised: June 18, 2019
  • Accepted: June 24, 2019
  • DOI: 10.5812/htaa.94241

To Cite: Bavandpour E, Bavandpour M, Karimi Z, Payandeh M, Shakiba E, et al. Safety and Efficacy of Tomotherapy for Lung Cancer Compared to Other Radiotherapy Techniques: A Systematic Review, Health Tech Asmnt Act. 2018 ; 2(1):e94241. doi: 10.5812/htaa.94241.

Abstract
Copyright © 2019, Health Technology Assessment in Action. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Methods
4. Results
5. Discussion and Conclusions
Footnotes
References
  • 1. Abreu CE, Ferreira PP, de Moraes FY, Neves WF Jr, Gadia R, Carvalho Hde A. Stereotactic body radiotherapy in lung cancer: An update. J Bras Pneumol. 2015;41(4):376-87. doi: 10.1590/S1806-37132015000000034. [PubMed: 26398758]. [PubMed Central: PMC4635958].
  • 2. Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol. 2016;11(1):115. doi: 10.1186/s13014-016-0693-8. [PubMed: 27600665]. [PubMed Central: PMC5012092].
  • 3. Monaco A, Caruso C, Giammarino D, Cianciulli M, Pressello MC, Donato V. Radiotherapy for inoperable non-small cell lung cancer using helical tomotherapy. Tumori. 2012;98(1):86-9. doi: 10.1700/1053.11504. [PubMed: 22495706].
  • 4. Bral S, Duchateau M, Versmessen H, Verdries D, Engels B, De Ridder M, et al. Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy. Cancer. 2010;116(1):241-50. doi: 10.1002/cncr.24732. [PubMed: 19918925].
  • 5. Song CH, Pyo H, Moon SH, Kim TH, Kim DW, Cho KH. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2010;78(3):651-8. doi: 10.1016/j.ijrobp.2009.08.068. [PubMed: 20207499].
  • 6. Nagai A, Shibamoto Y, Yoshida M, Inoda K, Kikuchi Y. Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis. Biomed Res Int. 2014;2014:473173. doi: 10.1155/2014/473173. [PubMed: 24995299]. [PubMed Central: PMC4065754].
  • 7. Casutt A, Bouchaab H, Beigelman-Aubry C, Bourhis J, Peters S, Lovis A, et al. Stereotactic body radiation therapy with helical-tomotherapy for medical inoperable early stages (I-IIIa) primary and second-primary NSCLC: Outcomes of the one-year experience and analysis of toxicities. J Nucl Med Radiat Ther. 2014;5(2). doi: 10.4172/2155-9619.1000183.
  • 8. Chen XR, Dong JN, Zhang F, Yao TL. Efficacy and safety of image-guidance radiotherapy by helical tomotherapy in patients with lung cancer. Medicine (Baltimore). 2018;97(1). e9243. doi: 10.1097/MD.0000000000009243. [PubMed: 29505510]. [PubMed Central: PMC5943132].
  • 9. Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM Jr, et al. Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial. Ann Thorac Surg. 2003;75(4):1097-101. doi: 10.1016/s0003-4975(02)04681-7. [PubMed: 12683544].
  • 10. Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006;1(8):802-9. [PubMed: 17409963].
  • 11. Jen YM, Lin HH, Su YF, Lin KT, Lin JC, Chang WC, et al. The outcome of cyberknife treatment for primary or metastatic malignant lung tumors. J Med Sci. 2014;34(4):145. doi: 10.4103/1011-4564.139183.
  • 12. Gibbs IC, Loo BW Jr. Cyberknife stereotactic ablative radiotherapy for lung tumors. Technol Cancer Res Treat. 2010;9(6):589-96. doi: 10.1177/153303461000900607. [PubMed: 21070081].
  • 13. Nuyttens JJ, Prevost JB, Praag J, Hoogeman M, Van Klaveren RJ, Levendag PC, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the Cyberknife: Marker placement and early results. Acta Oncol. 2006;45(7):961-5. doi: 10.1080/02841860600902205. [PubMed: 16982564].
  • 14. Brown WT, Wu X, Fowler JF, Garcia S, Fayad F, Amendola BE, et al. Lung metastases treated by Cyberknife image-guided robotic stereotactic radiosurgery at 41 months. South Med J. 2008;101(4):376-82. doi: 10.1097/SMJ.0b013e318167ad8d. [PubMed: 18360342].
  • 15. [No Author Listed]. Reports collection of health technology assessment in Iran. 1st ed. Tehran: Rah of Soraya; 2013.
  • 16. Canadian Agency for Drugs Technologies in Health. Tomotherapy, gamma knife, and cyberknife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: A systematic review of clinical effectiveness and cost-effectiveness. CADTH Technol Overv. 2010;1(3). e0119. [PubMed: 22977409]. [PubMed Central: PMC3411154].
  • 17. Kupelian P, Lee S, Lee P, Kamrava M, King C. Tomotherapy: Accurate treatment with fewer side effects. Department of Radiation Oncology. Los Angeles, CA: UCLA Medical Plaza; 2018. Available from: www.radonc.ucla.edu.
  • 18. Yang ZX, Shen JT, Li YP, Zhao K, Shi CH, Xiao Y, et al. Helical tomotherapy for cancer treatment: A rapid health technology assessment. J Evid Based Med. 2014;7(3):192-218. doi: 10.1111/jebm.12109. [PubMed: 25156336].
  • 19. De Bari B, Jumeau R, Bouchaab H, Vallet V, Matzinger O, Troussier I, et al. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients. Acta Oncol. 2016;55(6):767-73. doi: 10.3109/0284186X.2015.1120886. [PubMed: 27034083].
  • 20. Welsh JS, Lock M, Harari PM, Tome WA, Fowler J, Mackie TR, et al. Clinical implementation of adaptive helical tomotherapy: A unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat. 2006;5(5):465-79. doi: 10.1177/153303460600500503. [PubMed: 16981789].
  • 21. Boudreau R, Clark M, Nkansah E. Tomotherapy, gamma knife, and cyberknife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: A systematic review of clinical effectiveness and cost-effectiveness. Canadian Agency for Drugs and Technologies in Health; 2009.
  • 22. AHTA. Tomotherapy HI-ART system radiotherapy planning and treatment for cancer patients. 2009. 3 p.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments